Comparing two forms of aripiprazole injection for schizophrenia
Treatments studied
Part of Mental health clinical trials.
This study tests whether a new long-acting injection of aripiprazole (a medication for schizophrenia) works the same as the current version. It helps understand how the drug is absorbed and may offer a more convenient treatment option for people with stable schizophrenia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a schizophrenia diagnosis that has been stable for at least 28 days (no medication changes or hospital stays).
- You are currently taking up to two oral antipsychotic medications at a steady dose for at least 14 days.
- You are within a healthy weight range: at least 50 kg (110 lbs) for men and 45 kg (99 lbs) for women, with a BMI between 18.5 and 35.
- You do not have significant heart, liver, kidney, or other serious medical conditions, or recent history of stroke or seizures.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use effective birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
This study tests an extended-release form of the medication brexpiprazole, given as an injection, for people with schizophrenia. It aims to see how the drug moves through the body and how safe it is.
This trial tests a long-acting injectable form of cariprazine (AX251 LAI) for people with stable schizophrenia. You would receive one injection and stay at the clinic for 7 days to see how your body handles it and how well you tolerate it.
This study tests a new long-acting injection for schizophrenia compared to an existing oral medication. It aims to see how the body handles the drug and if it is safe and tolerable.
This trial tests a monthly injection of cariprazine (a medication for mental health conditions) in people who could benefit from it. It aims to see if the shot is safe, tolerable, and effective compared to taking pills every day.
This trial tests an investigational medication called VV119 for adults experiencing a sudden worsening of schizophrenia symptoms. It aims to see if the drug is safe and effective in reducing symptoms like delusions, hallucinations, and disorganized thinking.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.